A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study

被引:0
|
作者
Patrizia Vici
Giuseppe Colucci
Francesco Giotta
Domenico Sergi
Gianfranco Filippelli
Pasquale Perri
Claudio Botti
Enrico Vizza
Armando Carpino
Laura Pizzuti
Agnese Latorre
Diana Giannarelli
Massimo Lopez
Luigi Di Lauro
机构
[1] Regina Elena National Cancer Institute,Division of Medical Oncology B
[2] Oncologic Institute,Department of Medical and Experimental Oncology
[3] Division of Medical Oncology,Division of Surgery A
[4] S. Francesco Hospital,Division of Gynecological Oncology
[5] Regina Elena National Cancer Institute,Cardiologic Unit
[6] Regina Elena National Cancer Institute,Biostatistics Unit
[7] Regina Elena National Cancer Institute,undefined
[8] Regina Elena National Cancer Institute,undefined
来源
Journal of Experimental & Clinical Cancer Research | / 30卷
关键词
Anthracyclines; Lapatinib; Pegylated Liposomal Doxorubicin; Neutropenic Fever; Advanced Breast Cancer Patient;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas
    Buonadonna, Angela
    Scalone, Simona
    Lombardi, Davide
    Fumagalli, Arianna
    Guglielmi, Alessandra
    Lestuzzi, Chiara
    Polesel, Jerry
    Canzonieri, Vincenzo
    Lamon, Stefano
    Giovanis, Petros
    Gagno, Sara
    Corona, Giuseppe
    Mascarin, Maurizio
    Belluco, Claudio
    De Paoli, Antonino
    Fasola, Gianpiero
    Puglisi, Fabio
    Miolo, Gianmaria
    CANCERS, 2023, 15 (20)
  • [42] Non-pegylated liposomal doxorubicin and docetaxel as first-line treatment in metastatic breast cancer.
    Heilmann, V
    Eggemann, H
    Sommer, H
    Heinrich, G
    Blohmer, JU
    Mallmann, PK
    Krabisch, P
    Klare, P
    Schilling, J
    Kittel, K
    Elling, D
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 66S - 66S
  • [43] Sequential docetaxel followed by epirubicin-vinorelbine as first-line chemotherapy in advanced breast cancer
    Vici, P
    Foggi, P
    Colucci, G
    Capomolla, E
    Brandi, M
    Giotta, F
    Gebbia, N
    Di Lauro, L
    Valerio, MR
    Paoletti, G
    Belli, F
    Pizza, C
    Giannarelli, D
    Lopez, M
    ANTICANCER RESEARCH, 2005, 25 (2B) : 1309 - 1314
  • [44] A phase II trial of gemcitabine combined with vinorelbine as first-line chemotherapy for metastatic breast cancer
    Meshref, M. M.
    Samir, S.
    Saad, E.
    Gouda, Y.
    Elmesidy, S.
    Koheil, H.
    Elzawahri, H.
    Kandil, A.
    Abdelhamid, T.
    Zaki, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [45] Phase II trial of capecitabine and vinorelbine as first-line chemotherapy for metastatic breast cancer patients
    Ghosn, M
    Kattan, J
    Farhat, F
    Younes, F
    Gasmi, J
    ANTICANCER RESEARCH, 2006, 26 (3B) : 2451 - 2456
  • [46] Activity and safety of vinorelbine and capecitabine as first-line treatment in patients with metastatic breast cancer - a phase II trial
    Palumbo, R.
    Bernardo, A.
    Strada, M.
    Teragni, C.
    Poggi, G.
    Frascaroli, M.
    Amatu, A.
    Palumbo, I.
    Bernardo, G.
    EJC SUPPLEMENTS, 2008, 6 (07): : 177 - 177
  • [47] A Phase II Randomized Crossover Study of Liposomal Doxorubicin Versus Weekly Docetaxel in the First-line Treatment of Women With Metastatic Breast Cancer
    Yardley, Denise A.
    Burris, Howard A., III
    Spigel, David R.
    Clark, Bobby L.
    Vazquez, Elizabeth
    Shipley, Dianna
    Barton, John
    Thompson, Dana
    Montes, Ignacio
    Greco, F. Anthony
    Hainsworth, John D.
    CLINICAL BREAST CANCER, 2009, 9 (04) : 247 - 252
  • [48] Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women ≥65 years of age
    Addeo, Raffaele
    Faiola, Vincenzo
    Guarrasi, Rosario
    Montella, Liliana
    Vincenzi, Bruno
    Capasso, Elena
    Cennamo, Gregorio
    Rotundo, Maria Saveria
    Tagliaferri, Pierosandro
    Caraglia, Michele
    Del Prete, Salvatore
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (02) : 285 - 292
  • [49] Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women ≥65 years of age
    Raffaele Addeo
    Vincenzo Faiola
    Rosario Guarrasi
    Liliana Montella
    Bruno Vincenzi
    Elena Capasso
    Gregorio Cennamo
    Maria Saveria Rotundo
    Pierosandro Tagliaferri
    Michele Caraglia
    Salvatore Del Prete
    Cancer Chemotherapy and Pharmacology, 2008, 62
  • [50] Phase II study of vinorelbine, epirubicin and continuous 5-fluorouracil infusion as first line treatment in anthracycline naive metastatic breast cancer.
    Berruti, A
    Bitossi, R
    Gorzegno, G
    Donadio, M
    Nigro, C
    Ardine, M
    Bertetto, O
    Bottini, A
    Danese, S
    Bertone, E
    Sarobba, MG
    Farris, A
    Bellino, R
    Katsaros, D
    Castiglione, F
    Grassi, L
    Marinone, C
    Dogliotti, L
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S91 - S91